Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Retrospective Analysis for Patients With Hemophagocytosis in Bone Marrow
Completed
- Conditions
- Hemophagocytosis
- Interventions
- Other: Hemophagocytosis
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2015-11-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT02401932
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Hybrid Procedure in Patients With Persistent Atrial Fibrillation
Not Applicable
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Procedure: Hybrid procedure
- First Posted Date
- 2015-03-19
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT02392338
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Multicenter, PhaseⅣ, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02389920
International Extranodal NK/T-cell Lymphoma Project
Completed
- Conditions
- Extranodal NK/T-cell Lymphoma, Nasal Type
- First Posted Date
- 2015-03-12
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 770
- Registration Number
- NCT02386813
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Lateral Rectus Muscle and Anterior Segment Optical Coherence Tomography (AS-OCT)
Completed
- Conditions
- Intermittent Exotropia
- First Posted Date
- 2015-03-09
- Last Posted Date
- 2015-03-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02383381
Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
Phase 4
Completed
- Conditions
- Femur Head NecrosisFemoral Neck FracturesOsteoarthritis, Hip
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2015-03-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 639
- Registration Number
- NCT02379663
Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection
Phase 3
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Drug: Standard triple therapyDrug: Gemifloxacin-based triple therapy
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2015-02-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 252
- Registration Number
- NCT02368470
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of IARULIL® in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract
Phase 4
Completed
- Conditions
- Recurrent Cystitis
- Interventions
- Drug: hyaluronic acid and chondroitin sulphate
- First Posted Date
- 2015-02-19
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 105
- Registration Number
- NCT02366676
- Locations
- 🇰🇷
Samsung Medical Center, Seoul,, Korea, Republic of
XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy
- First Posted Date
- 2015-01-30
- Last Posted Date
- 2019-05-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT02350686
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 4
- Registration Number
- NCT02346032
© Copyright 2025. All Rights Reserved by MedPath